Program for all days

Better Kidney Health

The Interconnected Kidney

Preserving Kidney Health

The Smart Kidney

Plenary Sessions

WCN Courses

Spotlight Sessions

Special Sessions

Global Kidney Policy Forum

Welcome Event

Topical Networking

Poster Sessions

28 March 2026

Time	Session

8:30 a.m. 10 a.m.	Renal Pathology Course: Transplantation Related Kidney Diseases AhmedKalebi Moderator drkalebi@ahmedkalebi.comKenya PeterBoor Moderator pboor@ukaachen.deGermany SuryaSeshan Moderator svs2002@med.cornell.eduUnited States Update on Banff Transplant Pathology Classification AgnesFogo Speaker agnes.fogo@vanderbilt.eduUnited States Kidney Lesions Following Stem Cell Transplantation SuryaSeshan Speaker svs2002@med.cornell.eduUnited States Digital Pathology and Artificial Intelligence Applications in Kidney Transplant Pathology PeterBoor Speaker pboor@ukaachen.deGermany Q&A Session 301 - 302																		Tools to Strengthen Global Kidney Trials: Design, Innovative Endpoints, and Communication Across Regions 1 Breaking New Ground in Clinical Trials BrendanSmyth Moderator brendanjsmyth@gmail.comAustralia High Level Summary of the Two Previous Webinars AdeeraLevin Speaker alevin@providencehealth.bc.caCanada Designing Trials for Inclusivity and Generalizability Andrea Viecelli Speaker andrea.viecelli@usz.chSwitzerland Trials Without Borders RathikaKrishnasamy Speaker Rathika.Krishnasamy@health.qld.gov.auAustralia Use of Novel Tools in Kidney Research Pedro HenriqueFranca Gois Speaker pedro.francagois@health.nsw.gov.auAustralia Q&A Session 303																		Onco-Nephrology Course: Acute Kidney Injury (AKI) in the Cancer Patient AKI Due to Chemotherapy Diana CarolinaVargas Angel Speaker dcvargas@husi.org.coColombia AKI Due to Targeted Therapy MotokoYanagita Speaker motoy@kuhp.kyoto-u.ac.jpJapan AKI Due to Immunotherapy Maria JoseSoler Speaker mjsoler01@gmail.comSpain Roundtable Discussion KenarJhaveri Moderator. Kjhaveri@northwell.eduUnited States 304																		Conservative Kidney Management: What Are Kidney Supportive Care (KSC) and Conservative Kidney Management (CKM)? PeaceBagasha Moderator bagashap@gmail.comUganda SaraDavison Moderator sara.davison@ualberta.caCanada Yoshiyuki Kizawa Moderator yoshikizawa@md.tsukuba.ac.jp Introduction to concepts/principles of Kidney Supportive Care and Conservative Kidney Management SaraDavison Speaker sara.davison@ualberta.caCanada Joint Talk: Planning for conservative kidney management - A Tale of Two Cities BarnabyHole Speaker barnaby.hole@bristol.ac.ukUnited Kingdom PeaceBagasha Speaker bagashap@gmail.comUganda Essential Communication Skills for Successful Advance Care Planning BarnabyHole Speaker barnaby.hole@bristol.ac.ukUnited Kingdom Q&A Session 311 - 312																		Local Kidney Registries in Action: Regional Insights and Innovations Kidney Registries in Action: global collaboration to improve access to treatment and patient outcomes GeorginaIrish Moderator georgina@anzdata.org.auAustralia JunichiHoshino Moderator hoshino.junichi@twmu.ac.jpJapan Welcome FergusCaskey Speaker Fergus.Caskey@bristol.ac.ukUnited Kingdom Introduction ToshihideNaganuma Speaker m9643361@omu.ac.jpJapan Lessons From Developing a National Hemodialysis Registry in Nepal DibyaSingh Shah Speaker dibyasingh@hotmail.comNepal Status of Dialysis Therapy in Mongolia: Insights From the National Dialysis Registry AdiyaSaruultuvshin Speaker saruultuvshin@mnums.edu.mnMongolia Applying National Kidney Registry Data to Japanese Clinical Practice Guidelines JunichiHoshino Speaker hoshino.junichi@twmu.ac.jpJapan Panel Discussion 313 - 314																		Annual Review of Nephrology Course 1 KenjiMatsui Moderator kematsui@gmail.comUnited States MitchellRosner Moderator MHR9R@hscmail.mcc.virginia.eduUnited States SabineKaram Moderator sabinejkaram@gmail.comUnited States Update on Diabetes Kidney Disease Management SunitaBavanandan Speaker sbavanandan@gmail.comMalaysia New Drugs for Polycystic Kidney Disease MichelChonchol Speaker Michel.Chonchol@comcast.netUnited States B Cell Targeted Therapies for Glomerular Diseases RichardLafayette Speaker czar@stanford.eduUnited States Q&A Session 501 - 502																		Interventional Nephrology Course: Dialysis Access in Action: Mapping, Cannulation, and Volume Assessment Tunneled Central Venous Catheter Placement and Troubleshooting: Simulation-based Training BernardoMoguel González Speaker bernardomoguel@hotmail.comMexico Hoon SukPark Speaker cttailor@catholic.ac.krSouth Korea Hemodialysis Access: Venous Mapping, AVF Assessment, Ultrasound Maturity Evaluation, and Simulation-guided Cannulation ToshihideNaganuma Speaker m9643361@omu.ac.jpJapan VandanaNiyyar Speaker vniyyar@emory.eduUnited States Volume Assessment Using Lung Ultrasound and Inferior Vena Cava Imaging BhavnaBhasin-Chhabra Speaker bhasin-chhabra.bhavna@mayo.eduUnited States EduardoRios Argaiz Speaker lalo.argaiz@gmail.comMexico Q&A Session 503
10:30 a.m. 12 p.m.	Renal Pathology: Native Kidney Disease Pathology – Advances/Update Mineaki Kitamura Moderator minekitamura@nagasaki-u.ac.jpJapan PeterBoor Moderator pboor@ukaachen.deGermany Spectrum of IgG4 Related Kidney Diseases TakakoSaeki Speaker tsaeki04@gmail.comJapan Spectrum of Tropical Infections and Renal Lesions in Parasitic Diseases AhmedKalebi Speaker drkalebi@ahmedkalebi.comKenya From Uncertainty to Diagnosis: Genomics in Undetermined Kidney Disease LaurentMesnard Speaker laurent.mesnard@aphp.frFrance Q&A Session 301 - 302																		Tools to Strengthen Global Kidney Trials: Design, Innovative Endpoints, and Communication Across Regions 2 Global Trials Perspectives KatherineTuttle Moderator Katherine.Tuttle@providence.orgUnited States MegumiOshima Moderator mgm_oshima@yahoo.co.jpJapan VivekKumar Moderator enigma165@yahoo.co.inIndia Japanese Perspective MegumiOshima Speaker mgm_oshima@yahoo.co.jpJapan African Perspective RobertKalyesubula Speaker rkalyesubula@gmail.comUganda Insights on Consent Challenges in Low and Middle-income Countries ShuchiAnand Speaker sanand2@stanford.eduUnited States Closing the Loop: Returning Results to Participants: Why and How AdeeraLevin Speaker alevin@providencehealth.bc.caCanada BillWang Speaker billwang1968@yahoo.comHong Kong, China Q&A Session 303																		Onco-Nephrology Course: Electrolyte Disturbances in the Cancer Patient Hyponatremia in Patients with Cancer SanjeevNair Speaker docsvn@gmail.comIndia Hypercalcemia in Patients with Cancer MohamedHassanein Speaker hassanein.mh@gmail.comEgypt Hypomagnesemia and Hypophosphatemia in Patients With Cancer JolantaMalyszko Speaker jolmal@poczta.onet.plPoland Roundtable Discussion KenarJhaveri Moderator. Kjhaveri@northwell.eduUnited States 304																		Conservative Kidney Management: How to deliver CKM - A Focus on Symptom Management Managing Restless Legs, CKD-Associated Pruritus, and Insomnia in Conservative Kidney Management BrendanSmyth Speaker brendanjsmyth@gmail.comAustralia Management of Pain in Conservative Kidney Management PramoteEuasobhon Speaker pramoteo@hotmail.comThailand Management of Fatigue and Mental Health in Conservative Kidney Management PeaceBagasha Speaker bagashap@gmail.comUganda Q&A Session 311 - 312																		Real-World Data and Registries in Clinical Research AlejandroFerreiro-Fuentes Moderator aferreirofuentes@gmail.comUruguay FergusCaskey Moderator Fergus.Caskey@bristol.ac.ukUnited Kingdom Introduction GeorginaIrish Speaker georgina@anzdata.org.auAustralia Embedding Randomization in a National CKD Registry: The SACK Apixaban Study MarieEvans Speaker marie.evans@ki.seSweden Platform Trials Using Routine Data for Pediatric Rare Diseases DorotheaNitsch Speaker dorothea.nitsch@lshtm.ac.ukUnited Kingdom Lessons Learned From Hemodialysis and Peritoneal Dialysis Trials: ANZDATA Insights StephenMcdonald Speaker stephen.mcdonald@sa.gov.auAustralia Q&A 313 - 314																		Annual Review of Nephrology Course 2 SolaAoun Bahous Moderator sola.bahous@gmail.comLebanon Yoshihito Nihei Moderator y-nihei@juntendo.ac.jpJapan Linking Renal Pathology to Kidney Function Jonathan Barratt Speaker jb81@leicester.ac.ukUnited Kingdom Management of C3 Glomerulopathy: From Diagnosis to Targeted Therapy SHOICHIMARUYAMA Speaker marus@med.nagoya-u.ac.jpJapan Update on the Cardio-Kidney Metabolic Syndrome SolaAoun Bahous Speaker sola.bahous@gmail.comLebanon Q&A Session 501 - 502																		Interventional Nephrology Course: Ultrasound in Nephrology- From Diagnosis to Intervention Diagnostic Ultrasound of the Kidneys and Bladder ToshihideNaganuma Speaker m9643361@omu.ac.jpJapan VandanaNiyyar Speaker vniyyar@emory.eduUnited States Kidney Biopsy BernardoMoguel González Speaker bernardomoguel@hotmail.comMexico Hoon SukPark Speaker cttailor@catholic.ac.krSouth Korea Volume Assessment Using Cardiac Ultrasound and the VExUS Score BhavnaBhasin-Chhabra Speaker bhasin-chhabra.bhavna@mayo.eduUnited States EduardoRios Argaiz Speaker lalo.argaiz@gmail.comMexico Q&A Session 503
11 a.m. 11:15 a.m.	Professor Donal O'Donoghue Global Kidney Policy Forum: Opening Remarks A Turning Point for Kidney Health: Leveraging the WHO Resolution for Regional and National Impact Speaker: Marcello Tonelli, ISN President The GKPF and the 10 Global Kidney Health Recommendations Speaker: Ifeoma Ulasi, ISN AWG Chair 315
11:15 a.m. 12:05 p.m.	Professor Donal O'Donoghue Global Kidney Policy Forum: Japan’s CKD Strategy in Action — Lessons From an Aging Society Moderator: Ifeoma Ulasi, ISN AWG Chair Addressing Kidney Disease in Japan: How Does the National Policy Meet Global Commitments Speaker: Yosuke Yamada, Deputy Director Cancer and Disease Control Division Public Health Bureau the Ministry of Health, Labour, and Welfare Transforming Kidney Care Through National Strategy: A Nephrologist Perspective Speaker: Naoki Kashihara, Chair Professor and Vice President, Kawasaki Medical School, Department of Nephrology and Hypertension Living the Strategy: A Patient’s Perspective on Navigating Kidney Care in Japan Speaker: Takeshi Shukunobe, CEO, PPeCC,Inc. Financing Kidney Health: Sustainable and Innovative National Approaches Speaker: Yusuke Suzuki, Professor, Department of Nephrology, Juntendo University Faculty of Medicine Q&A Moderator: Ifeoma Ulasi, ISN AWG Chair 315
12:05 p.m. 12:55 p.m.	Professor Donal O'Donoghue Global Kidney Policy Forum: Advancing Kidney Health Across North and East Asia: Regional Challenges and Opportunities Moderator: Iqbal Hafidz, ISN AWG Deputy Chair Integrating Kidney Health into NCD Strategies: A Regional Perspective from WHO Speaker: Huong Tran, Director of Health Promotion, Disease Prevention and Control at WHO Regional Office for the Western Pacific Data-driven Kidney Health: The Taiwan Experience Speaker: Wu Mai Szu, President, Taipei Medical University Advancing Kidney Disease Prevention and Care in China Speaker: Luxia Zhang, Deputy Dean, National Institute of Health Data Science, Peking University Addressing Kidney Disease through the National Health Plan 2030 (HP2030) Speaker: Kook-Hwan Oh, Division of Nephrology, Department of Internal Medicine, Seoul University Bridging the Gap Between Policy and Patient Reality Speaker: Manvir Victor, ISN PLAG Chair Q&A Moderator: Iqbal Hafidz, ISN AWG Deputy Chair 315
12:15 p.m. 1:15 p.m.	Renal Pathology Course: Clinical-Pathologic Correlation Case Presentations Case Discussion 1 AgnesFogo Speaker agnes.fogo@vanderbilt.eduUnited States Case Discussion 2 SuchinWorawichawong Speaker suchin.wor@mahidol.ac.thThailand Case Discussion 3 Mineaki Kitamura Speaker minekitamura@nagasaki-u.ac.jpJapan Q&A 301 - 302																		Tools to Strengthen Global Kidney Trials: Design, Innovative Endpoints, and Communication Across Regions 3 Implementation Science in Action MichaelWalsh Moderator lastwalsh1975@gmail.comCanada Practical Aspects of Implementation Science; Hands-on Studies Tae WonYi Speaker taewon.yi@gmail.comCanada Value of Implementation Science RukshanaShroff Speaker Rukshana.Shroff@gosh.nhs.ukUnited Kingdom Implementation Science in Digital Health: Clinical Trials Using Mobile Applications for Patient Interventions YusukeSakaguchi Speaker sakaguchi@kid.med.osaka-u.ac.jpJapan Take Home Messages MegJardine Speaker meg.jardine@sydney.edu.auAustralia 303																		Onco-Nephrology Course: Onco-Nephrology in Special Populations Onco-nephrology in the Kidney Transplant Population RobertCarroll Speaker robert.carroll@health.sa.gov.auAustralia Onco-Hypertension: Mechanisms, Monitoring, and Management SabineKaram Speaker sabinejkaram@gmail.comUnited States GFR Estimation in Patients With Cancer ShuchiAnand Speaker sanand2@stanford.eduUnited States Q&A and Final Remarks KenarJhaveri Moderator. Kjhaveri@northwell.eduUnited States 304																		Conservative Kidney Management: How to deliver CKM - Why It Is Everybody's Business Managing Metabolic Complications of Kidney Failure in Conservative Kidney Management SaraDavison Speaker sara.davison@ualberta.caCanada End-of-Life Care in Conservative Kidney Management: Symptom-focused Approaches NandiniVallath Speaker aanandini@gmail.comIndia Q&A Session 311 - 312																		From Definition to Data: Advancing Standardisation in CKD Registries MarieEvans Moderator marie.evans@ki.seSweden StephenMcdonald Moderator stephen.mcdonald@sa.gov.auAustralia Why We Need Standardised Data in CKD Registries AlejandroFerreiro-Fuentes Speaker aferreirofuentes@gmail.comUruguay UK Experience in Harmonizing Routine CKD Data for Research SamiraBell Speaker stbell@dundee.ac.ukUnited Kingdom Overcoming Barriers to Global CKD Data Standardization JamesWetmore Speaker james.wetmore@hcmed.orgUnited States Q&A 313 - 314																		Annual Review of Nephrology Course 3 BiancaDavidson Moderator bianca.davidson@gmail.comSouth Africa SHOICHIMARUYAMA Moderator marus@med.nagoya-u.ac.jpJapan How Do I Manage Hepatorenal Syndrome? Lori-AnnFisher Speaker lori2k15@gmail.comJamaica How Do I Manage: Checkpoint Inhibitor-associated AKI MitchellRosner Speaker MHR9R@hscmail.mcc.virginia.eduUnited States Q&A Session 501 - 502																		Interventional Nephrology Course: PD Catheter Simulation Introduction BernardoMoguel González Speaker bernardomoguel@hotmail.comMexico 503
12:55 p.m. 1 p.m.	Professor Donal O'Donoghue Global Kidney Policy Forum: Closing Remarks and Next Steps Speaker: Ifeoma Ulasi, ISN AWG Chair 315
2 p.m. 3:30 p.m.	Plenary Lecture 1: Donald Seldin Lecture - Dynamics of the Function and Regulation of the Endoplasmic Reticulum and WCN'26 Opening Ceremony (Kazutoshi Mori, Japan) Jean Hamburger Award MarcelloTonelli Moderator cello@ucalgary.caCanada MasaomiNangaku Moderator mnangaku@m.u-tokyo.ac.jpJapan SunitaBavanandan Moderator sbavanandan@gmail.comMalaysia KazutoshiMori Speaker mori.kazutoshi.8r@kyoto-u.ac.jpJapan TakashiKadowaki Speaker t-kadowaki@toranomon.kkr.or.jpJapan Welcome and ISN Presidential Address MarcelloTonelli Speaker cello@ucalgary.caCanada Jean Hamburger Award Presentation Welcome Speech by JSN President MasaomiNangaku Speaker mnangaku@m.u-tokyo.ac.jpJapan Welcome Speech by APSN President XueqingYU Speaker yuxueqing@gdph.org.cnChina Dynamics of the Function and Regulation of the Endoplasmic Reticulum KazutoshiMori Speaker mori.kazutoshi.8r@kyoto-u.ac.jpJapan ISN Film Event Winner Presentation Main Hall
3:45 p.m. 4:45 p.m.	The Gut–Kidney Axis in CKD: Mechanistic Insights and Therapeutic Perspectives The Gut as a Central Hub of Inter-Organ Cross-Talk in Chronic Kidney Disease LaetitiaKoppe Speaker laetitia.koppe@chu-lyon.frFrance Deciphering Gut Dysbiosis: Is It Age or Kidney Disease? JohannesHolle Speaker Johannes.Holle@med.uni-tuebingen.deGermany Inflammation Under Neural Control: The Gut-Brain-Kidney Triad in Acute Kidney Injury ShinjiTanaka Speaker shitanaka@m.u-tokyo.ac.jpJapan Q&A 301 - 302														Cutting Edge Science in Nephrotic Syndrome/FSGS Genetics of Nephrotic Syndrome and FSGS DanielGale Speaker d.gale@ucl.ac.ukUnited Kingdom Immunology of Podocyte Injury: Nephrotic Syndrome and FSGS Hans-JoachimAnders Speaker hjanders@med.uni-muenchen.deGermany New Translational Insights in B-cell Targeted Therapies in Nephrotic Syndrome/FSGS NicolaTomas Speaker n.tomas@uke.deGermany Q&A Session 303														AI in Kidney Care: From Predictive Models to Pathology Support Korean Society of Nephrology Named Session Hyeong Cheon Park Moderator amp97@yuhs.acKorea Deep Learning in CKD Risk Stratification Using AI to Predict AKI in Critical Care Nephrology Yu HuiZHANG Speaker zhangyuhui9107@foxmail.comChina AI-enhanced Analysis of Kidney Biopsies IsaoMatsui Speaker matsui@kid.med.osaka-u.ac.jpJapan Q&A 304														Expanding Kidney Care Access Through Non-physician Workforce Models Becky MingyaoMa Moderator mymbecky@gmail.comHong Kong, China Tae WonYi Moderator taewon.yi@gmail.comCanada Non-physician Healthcare Models in CKD Care: What They Are and How to Build Them Carmen ElenaCervantes Speaker ccervan2@jhmi.eduUnited States Empowering Primary-level Healthcare Providers Through Targeted Kidney Health Education: Lessons from India PritiMeena Speaker pritimn@gmail.comIndia Survey of Non-physician Healthcare Workers on Early CKD Detection: Preliminary Results Ana CatalinaAlvarez Elias Speaker anacatalina.alvarezelias@rriny.comUnited States Expanding CKD Care Capacity Using Non-physician Providers in Fiji Yogeshni Chandra Speaker chandra_yogi@yahoo.comFiji Building Community Kidney Care in Nigeria Through Non-physician Healthcare Workers ChimezieOkwuonu Speaker getchimezie@yahoo.comNigeria Curated Discussion 311 - 312														ISN-WIN- WIN India-WIN Africa Joint Session: Bridging the Gap: Addressing Gender Disparities in Kidney Health Women in Nephrology (WIN): Breaking Barriers in Kidney Health - Gender Disparities in CKD and Dialysis MalaSachdeva Speaker msachdeva@northwell.eduUnited States WIN-India: The Social Construct of Organ Donation -Are Women Forced to Donate? PriyamvadaP S Speaker priyamvadaps@gmail.comIndia WIN-Africa: Trials And Tribulations: Improving Randomized Controlled Trials- How Reporting Outcomes By Sex/gender Can Make A Difference, And Barriers To Inclusion KhalidaBulhan - Soki Speaker drkbsoki@gmail.comKenya Q&A 313 - 314														Advancing Sustainable Kidney Care: Evidence and Implementation The Latest Evidence on the Environmental Impact of Kidney Care VivekanandJha Speaker vjha@georgeinstitute.org.inIndia Sustainable Kidney Care Using the GREEN-K Toolkit Winston Wing ShingFung Speaker winstonwsfung@hotmail.comHong Kong, China Greening Kidney Care in Low- and Middle-income Countries MohamedBen Hmida Speaker mohamedbenhmida148@gmail.comTunisia Q&A Session 315														The Future of AKI Care: New Therapies, Recovery Paradigms, and Global Equity Chinese Society of Nephrology Named Session XiaoqiangDing Moderator 13916517457@163.comChina Global Burden of AKI: Challenges and Barriers NattachaiSrisawat Speaker nattachai.sr@chula.ac.thThailand AKI and proteinuria Chi-yuanHsu Speaker Chi-yuan.Hsu@ucsf.eduUnited States Novel Treatments in Septic Acute Kidney Injury Kent Doi Speaker kentdoi@m.u-tokyo.ac.jpJapan New Strategies to Promote Recovery After AKI MarliesOstermann Speaker m.ostermann@nhs.netUnited Kingdom Q&A 501 - 502														CKD-MBD in Practice: Challenges, Controversies, and Consensus The Evolving Biology of CKD-MBD: Implications for Clinical Care MarcVervloet Speaker Marc.Vervloet@radboudumc.nlNetherlands Key Outcomes From the KDIGO CKD-MBD Controversies Conference Growing Up With Chronic Kidney Disease-Mineral and Bone Disorder: Pediatric Challenges RukshanaShroff Speaker Rukshana.Shroff@gosh.nhs.ukUnited Kingdom Q&A Session 503														HIT! High Impact Clinical Trials 1 DavidWheeler Moderator d.wheeler@ucl.ac.ukUnited Kingdom KatherineTuttle Moderator Katherine.Tuttle@providence.orgUnited States REMODEL Trial Overview: Framework and Key Outcomes PetterBjornstad Speaker pettermb@uw.eduUnited States Semaglutide Improves Kidney Outcomes Regardless Of SGLT2i Use In People With Chronic Kidney Disease And Type 2 Diabetes: Post-hoc Analysis The Remodel Trial DavidCherney Speaker david.cherney@uhn.on.caCanada Aldosterone Blockade for Health Improvement Evaluation in End-stage Renal Disease Trial (ACHIEVE) MichaelWalsh Speaker lastwalsh1975@gmail.comCanada B-cell Targeted Therapy for Idiopathic Nephrotic Syndrome: Results of the Phase III Global Multicenter Inshore Trial Evaluating Efficacy and Safety of Obinutuzumab vs Mycophenolate Mofetil JulienHogan Speaker julien.hogan2@aphp.frFrance Q&A Session Main Hall
5 p.m. 6:30 p.m.	Welcome Event Exhibition Hall																																																															Young Nephrologists Quiz-a-Thon IV: Japan edition Spotlight Stage 2
5:30 p.m. 6:30 p.m.	Moderated Poster Session Exhibition Hall
6 p.m. 6:45 p.m.	Spotlight on ISN-GKHA: Tracking a Decade of Global Kidney Health Progress Tracking the Evolution of Kidney Health Systems: Insights from ISN-GKHA 2017–2023 GeorginaIrish Speaker georgina@anzdata.org.auAustralia From Data to Action: How the ISN-GKHA Map Drives Policy and Advocacy MarinaWainstein Speaker marinawainstein@outlook.comArgentina Looking Ahead: Priorities and Plans for the ISN-GKHA 2027 Edition AminuBello Speaker aminu1@ualberta.caCanada Spotlight Stage 1																																																															ISN Community Film Event: Kidney Stories from Around the World Spotlight Stage 2

29 March 2026

Time	Session

8:10 a.m. 9:10 a.m.	Industry Symposium 5 HiddoLambers Heerspink Moderator H.J.Lambers.Heerspink@umcg.nlNetherlands NaokiKashihara Moderator kashinao@med.kawasaki-m.ac.jpJapan Clinical Impacts and Importance of Minimizing Drug Approval Delay NaokiKashihara Speaker kashinao@med.kawasaki-m.ac.jpJapan HCE (hierarchical composite end points) and eGFR slope, as potential solutions to delays in approval HiddoLambers Heerspink Speaker H.J.Lambers.Heerspink@umcg.nlNetherlands Bridging Academia and Regulators in Kidney Drug Development: Insights from Japan MototsuguTanaka Speaker mototsugu.tanaka@gmail.comJapan Panel Discussion DustinLittle Moderator dustin.little@astrazeneca.comUnited States HiddoLambers Heerspink Speaker H.J.Lambers.Heerspink@umcg.nlNetherlands MototsuguTanaka Speaker mototsugu.tanaka@gmail.comJapan NaokiKashihara Speaker kashinao@med.kawasaki-m.ac.jpJapan 301 - 302																												Industry Symposium 3 AkiraNishiyama Moderator nishiyama.akira@kagawa-u.ac.jpJapan MarikoMiyazaki Moderator mamiyaza@venus.dti.ne.jpJapan Urinary Uric Acid Excretion and Kidney Outcome YOSHITAKAISAKA Speaker isaka@kid.med.osaka-u.ac.jpJapan Uric Acid and Progression of DKD JunWada Speaker junwada@okayama-u.ac.jpJapan 304																												Industry Symposium 1 MasaomiNangaku Moderator mnangaku@m.u-tokyo.ac.jpJapan Advanced Data Science in CKD Management YuichiroYano Speaker y.yano@juntendo.ac.jpJapan An Integrated Approach to Cardio-Renal-Metabolic Disorders : Addressing Hypertension and Dyslipidemia KOUICHITAMURA Speaker tamukou@yokohama-cu.ac.jpJapan 315																												Industry Symposium 6 Jonathan Barratt Moderator jb81@leicester.ac.ukUnited Kingdom What makes IgA pathogenic in IgA nephropathy? YusukeSuzuki Speaker yusuke@juntendo.ac.jpJapan The role of B Cells in IgA nephropathy HeatherReich Speaker Heather.Reich@uhn.caCanada Targeting pathogenic IgA in IgA nephropathy Jonathan Barratt Speaker jb81@leicester.ac.ukUnited Kingdom 501 - 502																												Industry Symposium 4 Tak Mao, DanielChan Moderator dtmchan@hku.hkHong Kong, China Intestinal Phosphate Absorption Mechanisms UpToDate -Tenapanor and Future Perspectives- HirokoSegawa Speaker segawa@tokushima-u.ac.jpJapan CKD-MBD Guideline Revision in Japan: The Journey and Global Implications HirotakaKomaba Speaker hkomaba@tokai.ac.jpJapan 503																												Industry Symposium 2 KaoriHayashi Moderator kaorihayashi@keio.jpJapan Impact of Anti-Nephrin Antibodies: An Updated Understanding of the Pathogenesis of Nephrotic Syndrome TomokoHorinouchi Speaker tomoko.hatono@gmail.comJapan Recent Advances in Immunosuppressive Therapy for Refractory Nephrotic Syndrome in Children RikuHamada Speaker hamariku@gmail.comJapan 303
9:25 a.m. 10:55 a.m.	Hypertension Updates: New Rules, Tools, Paths and Plans TaraChang Moderator tichang@stanford.eduUnited States New Rules: Global Updates in Blood Pressure Guidelines TaraChang Speaker tichang@stanford.eduUnited States What Nephrologists Need to Know About Novel Antihypertensive Treatments Seung HyeokHan Speaker hansh@yuhs.acSouth Korea Implementing the Global Hearts Program to Improve Population Blood Pressure Control SwapnilHiremath Speaker shiremath@toh.caCanada Optimizing Hypertension Management Across the Lifespan Magdalena Madero Speaker madero.magdalena@gmail.comMexico Q&A 301 - 302																								ISN - APSN Joint Session Sydney Tang Moderator scwtang@hku.hkHong Kong, China IgA Nephropathy Study: Current and Perspective XueqingYU Speaker yuxueqing@gdph.org.cnChina Optimizing Management of Lupus Nephritis – The Clinical, The Bytes and The Bench DesmondYap Speaker desmondy@hku.hkHong Kong, China From Data to Discovery: Insights from ADPKD Registries Across the Asia-Pacific KornchanokVareesangthip Speaker kornchanok.ploy@gmail.comThailand Genetics of Chronic Kidney Disease in East Asians YukaSugawara Speaker ysuga-tky@m.u-tokyo.ac.jpJapan Q&A 303																								Dissecting the Kidney in Space: From Molecules to Microenvironments Applying Spatial Transcriptomics to Kidney Disease BERNHARDDUMOULIN Speaker bernhard.dumoulin@gmail.comUnited States A Systems Biology Approach to Tissue Mapping MatthiasKretzler Speaker kretzler@umich.eduUnited States Kidney Tissue Specific Gene Targeting TobiasHuber Speaker t.huber@uke.deGermany Envision Clinical Application AgnesFogo Speaker agnes.fogo@vanderbilt.eduUnited States Q&A 304																								Big Data Lab: Using Open Kidney Disease Data Resources for Research MatthiasKretzler Moderator kretzler@umich.eduUnited States Pathomic-driven Tissue Interrogation: Harnessing Collaborative Intelligence and Data Integration for Diagnostic Innovation LauraBarisoni Speaker laura.barisoni@duke.eduUnited States Integrating Multiscale Data to Decode Kidney Disease Mechanisms NilsGehlenborg Speaker nils@hms.harvard.eduUnited States Exploring Single-cell and Spatial Datasets Using the Kidney Precision Medicine Project Atlas and Human Cell X Gene Tools NikkiBonevich Speaker bonevicn@med.umich.eduUnited States Training Session Introduction: Nephroseq and TranSMART for Global Kidney Data Mining HeatherAscani Speaker ascanihk@med.umich.eduUnited States Q&A 315																								ISN-KDIGO Joint Session: Implementing Updated KDIGO AKI/AKD Guidelines Worldwide Kent Doi Moderator kentdoi@m.u-tokyo.ac.jpJapan Key Changes in AKI and AKD Definitions and Prognosis SamiraBell Speaker stbell@dundee.ac.ukUnited Kingdom Identifying and Preventing AKI and AKD in High-risk Scenarios MarliesOstermann Speaker m.ostermann@nhs.netUnited Kingdom Clinical Management of Acute Kidney Injury and Acute Kidney Disease VivekanandJha Speaker vjha@georgeinstitute.org.inIndia Optimizing Kidney Replacement Therapy in Acute Kidney Injury and Acute Kidney Disease NattachaiSrisawat Speaker drnattachai@yahoo.comThailand Q&A 501 - 502																								B Cell Targeting in Glomerular Disease A Role for Kidney Resident B/plasma Cells in Kidney Disease Progression? HeatherReich Speaker Heather.Reich@uhn.caCanada B Cell Activating Factor and A Proliferation-inducing Ligand Signaling in Glomerular Disease HongZhang Speaker hongzh@bjmu.edu.cnChina B Cell Targeted Therapies in Glomerular Diseases RichardLafayette Speaker czar@stanford.eduUnited States The Future of B Cell Therapies in the Treatment of Glomerular Diseases Jonathan Barratt Speaker jb81@leicester.ac.ukUnited Kingdom Q&A Session 503																								HIT! High Impact Clinical Trials 2 - New Insights Into Ongoing Trials AdeeraLevin Moderator alevin@providencehealth.bc.caCanada Andrea Viecelli Moderator andrea.viecelli@usz.chSwitzerland RobertoPecoits-Filho Moderator roberto.pecoits@arborresearch.orgUnited States RESOLVE Trial: Sodium Concentration in Dialysis Populations — a Global Cluster Randomized Study MegJardine Speaker meg.jardine@sydney.edu.auAustralia Q&A Key Aspects of the VOICE Clinical Trial on Anemia in Dialysis Patients ShuchiAnand Speaker sanand2@stanford.eduUnited States Q&A TEACH-PD Cluster Randomized Controlled Trial: Targeted Education ApproaCH to improve Peritoneal Dialysis Outcomes JosephineChow Speaker Josephine.Chow@health.nsw.gov.auAustralia Q&A The Renal Life Cycle: Development, Maturity, and Decline HiddoLambers Heerspink Speaker H.J.Lambers.Heerspink@umcg.nlNetherlands Q&A Randomized Embedded Adaptive Platform Clinical Trial in South Asian Kidney Biopsy-proven Primary Glomerular Diseases: Multi-center, Multi-arm and Multi-stage- the Story So Far Joint Presentation Selvin Sundar RajMani Speaker selvinsr@gmail.comIndia SuceenaAlexander Speaker suceena@gmail.comIndia Q&A ASPIRE Trial: Aspirin Use in Dialysis Patients in China XueqingYU Speaker yuxueqing@gdph.org.cnChina Q&A Main Hall
11 a.m. 11:45 a.m.	Big Data Lab 1 - Nephroseq 321																																																								Industry Spotlight Session 10+12 SHOICHIMARUYAMA Moderator marus@med.nagoya-u.ac.jpJapan A Snapshot of aHUS SHOICHIMARUYAMA Speaker marus@med.nagoya-u.ac.jpJapan The aHUS Clinical Picture AnujaJava Speaker ajava@wustl.eduUnited States Highlighting AHUS Associated With Triggers WaiLim Speaker wai.lim@health.wa.gov.auAustralia Q&A Spotlight Stage 1																																																								Industry Spotlight Session 9 HidetoshiKanai Moderator kanai8140002@yahoo.co.jpJapan Translating Intention into Action: Growing and Sustaining Home Dialysis Program HidetoshiKanai Speaker kanai8140002@yahoo.co.jpJapan Q&A Session HidetoshiKanai Speaker kanai8140002@yahoo.co.jpJapan Spotlight Stage 2
11:35 a.m. 12:35 p.m.	Plenary Lecture 2: Podocytopathies: Knowns and Unknowns (Paola Romagnani, Italy) Bywaters Award AkiraNishiyama Moderator nishiyama.akira@kagawa-u.ac.jpJapan LizLightstone Moderator l.lightstone@imperial.ac.ukUnited Kingdom Sydney Tang Moderator scwtang@hku.hkHong Kong, China PaolaRomagnani Speaker paola.romagnani@unifi.itItaly Bywaters Award Presentation Podocytopathies: Knowns and Unknowns PaolaRomagnani Speaker paola.romagnani@unifi.itItaly Main Hall
12:45 p.m. 1:30 p.m.	The Global Shortage of Renal Nurses Ana Elizabeth Figueiredo Moderator. anaef@pucrs.brBrazil Spotlight Stage 1
12:50 p.m. 1:50 p.m.	Industry Symposium 17 YusukeSuzuki Moderator yusuke@juntendo.ac.jpJapan Exploring the Role of APRIL in IgA Nephropathy: Pathogenesis to Progression Chee KayCheung Speaker ckc15@leicester.ac.ukUnited Kingdom HeatherReich Speaker Heather.Reich@uhn.caCanada 301 - 302																												Industry Symposium 14 VivekanandJha Moderator vjha@georgeinstitute.org.inIndia Pathophysiology and Emerging Targeted Therapies in IgAN Yoshihito Nihei Speaker y-nihei@juntendo.ac.jpJapan Disease Pathways and Emerging Therapeutic Strategies in Primary Membranous Nephropathy VivekanandJha Speaker vjha@georgeinstitute.org.inIndia Mechanism-Based Therapeutic Advances in AMR in Kidney Transplantation SteveChadban Speaker Steve.Chadban@health.nsw.gov.auAustralia 303																												Industry Symposium 15 EdwinaBrown Moderator e.a.brown@imperial.ac.ukUnited Kingdom A Patient’s Perspective: What Shared Decision-Making Really Means for Me TsutomuFuruzono Speaker furuzono@waka.kindai.ac.jpJapan Why SDM in Dialysis Still Falls Short: Understanding the Gaps YasuhiroKomatsu Speaker komayasu@gunma-u.ac.jpJapan Breaking Through Barriers: Practical Strategies to Make Shared Decision-Making Work EdwinaBrown Speaker e.a.brown@imperial.ac.ukUnited Kingdom 304																												Industry Symposium 13 KeiFukami Moderator fukami@med.kurume-u.ac.jpJapan The Importance of Guideline Directed Therapy Christoph Wanner Speaker wanner_c@ukw.deGermany Long-term Management of Hyperkalemia with Safety NaokiKashihara Speaker kashinao@med.kawasaki-m.ac.jpJapan 315																												Industry Symposium 18 ShigeruShibata Moderator shigeru.shibata@med.teikyo-u.ac.jpJapan Hypertension Management Aimed at Achieving Target Blood　Pressure : The Clinical Utility of Mineralocorticoid Receptor Antagonists HajimeNagasu Speaker hajimenagasu@kms-ndh.comJapan 501 - 502																												Industry Symposium 16 MotokoYanagita Moderator motoy@kuhp.kyoto-u.ac.jpJapan Welcome & Introduction MotokoYanagita Speaker motoy@kuhp.kyoto-u.ac.jpJapan Orchestrating Excellence: KDIGO’s Guidance on the Management of IgA Nephropathy Sydney Tang Speaker scwtang@hku.hkHong Kong, China Setting the Tempo: The Importance of Early Diagnosis and Treatment in IgA Nephropathy Maria JoseSoler Speaker mjsoler01@gmail.comSpain A Harmonious Approach: Simultaneously Targeting Both Drivers VladoPerkovic Speaker vlado.perkovic@unsw.edu.auAustralia A Note of Hope: Reimagining the Outcomes for Patients With IgA Nephropathy MotokoYanagita Speaker motoy@kuhp.kyoto-u.ac.jpJapan Summary & Close MotokoYanagita Speaker motoy@kuhp.kyoto-u.ac.jpJapan 503
1:30 p.m. 2 p.m.	The Dialysis Games RashaDarwish Speaker dr.rasha-darwish@hotmail.comEgypt SourabhSharma Speaker drsourabh05@gmail.comIndia Spotlight Stage 2
2:10 p.m. 3:10 p.m.	Home Dialysis Revolution: Implementation Strategies and Outcomes AdrianLiew Moderator draliew2@gmail.comSingapore Overcoming Barriers to Peritoneal Dialysis Implementation: The Role of the International Home Dialysis Consortium SimonDavies Speaker simonj.davies55@gmail.comUnited Kingdom Does Home Dialysis Improve Patient Outcomes? ChristopherChan Speaker christopher.chan@uhn.caCanada Beyond Traditional Boundaries: Wearable Artificial Kidneys and Portable Dialysis Technologies MarjorieFoo Speaker marjorie.foo.w.y@singhealth.com.sgSingapore Q&A 301 - 302																					ISN-PKD Foundation Joint Session - the future of PKD research and care Introduction of the Lillian Jean Kaplan Prize for PKD & Award Presentation VicenteTorres Moderator torres.vicente@mayo.eduUnited States Kaplan Prize winner: Disease modifying drugs for ADPKD: a rapidly evolving field. RonaldGansevoort Speaker r.t.gansevoort@umcg.nlNetherlands Platform trials in PKD: Opportunities and Challenges MegJardine Speaker meg.jardine@sydney.edu.auAustralia Is There a Role for SGLT2 Inhibitors and GLP Analogues in Treating PKD MichelChonchol Speaker Michel.Chonchol@comcast.netUnited States Q&A 303																					Why Primary and Community Care Matter for Kidney Health Named Session by the Indian Society of Nephrology (Indian SN) Shyam BihariBansal Moderator drshyambansal@gmail.comIndia Magdalena Madero Moderator madero.magdalena@gmail.comMexico My Kidneys and Me: A Digital Platform for Empowering CKD Self-Management Community-Driven Innovation: Redesigning CKD Care in Ghana’s Health System Community-based Primary Care CKD Detection and Management in Thailand TalerngsakKanjanabuch Speaker golfnephro@hotmail.comThailand Group-based Care Models for Chronic Kidney Disease: A Latin American Perspective PaulaMarioli Speaker paulamarioli@renalida.comArgentina Q&A 304																					ISN-WKD Joint Session: Kidney Health for All — Caring for People, Protecting the Planet DinaAbdellatif Moderator dina.abdellatif@gmail.comEgypt Li-LiHsiao Moderator lhsiao@bwh.harvard.eduUnited States ManjushaYadla Moderator manjuyadla@gmail.comIndia Key Takeaways from the 2026 WKD Editorial: Shaping the Future of Kidney Health DinaAbdellatif Speaker dina.abdellatif@gmail.comEgypt Kidney Health and Planetary Health: An Intricate Relationship NatarajanGopalakrishnan Speaker srigola751@yahoo.comIndia How the Patient Voice Shapes Kidney Care and Research NicoleScholes-Robertson Speaker nicole.scholes-robertson@sydney.edu.auAustralia Driving Change in Kidney Care: Lessons and Tools That Work Augusto CesarSoares dos Santos Junior Speaker acssjunior@hotmail.comBrazil Q&A 315																					ISN - EASD Joint Session: Crossroads of Nephrology and Diabetes: From Bench to Bedside Efficacy and Safety Results of Atrasentan in Patients With Iga Nephropathy on Sodium‚äìglucose Co-transporter 2 Inhibitors: Phase II, Randomized, Placebo-controlled, Crossover Trial (ASSIST) JanakaKaralliedde Speaker j.karalliedde@kcl.ac.ukUnited Kingdom Beyond HbA1c: Continuous Glucose Monitoring in Kidney Disease Care JuliaMader Speaker julia.mader@medunigraz.atAustria Drug Development in Diabetic Kidney Disease PeterRossing Speaker Peter.Rossing@regionh.dkDenmark Q&A 501 - 502																					Rare Kidney Disease Update Advances in C3G Diagnosis and Treatment HernánTrimarchi Speaker htrimarchi@hotmail.comArgentina Atypical Hemolytic Uremic Syndrome: Current Concepts and Management DavidKavanagh Speaker David.Kavanagh@newcastle.ac.ukUnited Kingdom Lupus LizLightstone Speaker l.lightstone@imperial.ac.ukUnited Kingdom Understanding IgA Nephropathy Today HeatherReich Speaker Heather.Reich@uhn.caCanada Q&A 503																					HIT! High Impact Clinical Trials 3 In IgA Nephropathy HeatherReich Moderator Heather.Reich@uhn.caCanada Sydney Tang Moderator scwtang@hku.hkHong Kong, China YusukeSuzuki Moderator yusuke@juntendo.ac.jpJapan Efficacy and Safety Results of Atrasentan in Patients With IgA Nephropathy on Sodium‚ äìglucose Co-transporter 2 Inhibitors: Phase II, Randomized, Placebo-controlled, Crossover Trial (Assist) HiddoLambers Heerspink Speaker H.J.Lambers.Heerspink@umcg.nlNetherlands Efficacy and Safety of a Targeted-release Formulation of Budesonide (HR19042 Capsules) in Patients With Primary IgA Nephropathy: A Randomized, Double-blind, Multicenter, Placebo-controlled Phase 2/3 Trial XiaobingYang Speaker yxb7829@163.comChina Efficacy and Safety of Iptacopan in Patients With IgA Nephropathy (IgAN): Final 24-month Results From the Phase III APPLAUSE-IgAN Study VladoPerkovic Speaker vlado.perkovic@unsw.edu.auAustralia Q&A Main Hall																					Industry Spotlight Session 20 PeterZipfel Moderator pzipfel@elevabiologics.comGermany BerndJilma Speaker bernd.jilma@meduniwien.ac.atAustria Spotlight Stage 1
2:30 p.m. 3 p.m.	Industry Spotlight Session 19 DavidCherney Moderator david.cherney@uhn.on.caCanada Welcome and introduction DavidCherney Moderator david.cherney@uhn.on.caCanada More than CKD: identifying and managing CV risk in patients With CKD DavidCherney Speaker david.cherney@uhn.on.caCanada Audience Q&A DavidCherney Moderator. david.cherney@uhn.on.caCanada Toshiyuki Ko Moderator. tkou-tky@umin.ac.jpJapan From the kidneys to the heart: practical management tools for CV risk in patients with CKD Toshiyuki Ko Speaker tkou-tky@umin.ac.jpJapan Audience Q&A DavidCherney Moderator. david.cherney@uhn.on.caCanada Toshiyuki Ko Moderator. tkou-tky@umin.ac.jpJapan Summary and close DavidCherney Moderator david.cherney@uhn.on.caCanada Spotlight Stage 2
3:15 p.m. 4 p.m.	Big Data Lab 2 - Kidney Tissue Atlas 321																																																																Industry Spotlight Session 21 HironoriKobayashi Moderator hkoba1974@gmail.comJapan Utilizing Remote Patient Management in PD Treatment: Sharesource & MyPD Enables Team-Based Care and Healthcare Collaboration HironoriKobayashi Speaker hkoba1974@gmail.comJapan Q&A Session HironoriKobayashi Speaker hkoba1974@gmail.comJapan Spotlight Stage 2
3:50 p.m. 4:50 p.m.	Industry Digest: Insights into Latest Innovations from Scientific Leads Advancing the Next Wave of Therapies in Chronic Kidney Disease DustinLittle Speaker dustin.little@astrazeneca.comUnited States Effects of Finerenone on Biomarkers: Mechanistic Insights From Proteomic Analyses in Clinical Trials MarioBerger Speaker mario.berger@bayer.comGermany Future Directions in CRM Care: Advancing Research and Therapeutic Innovation AntonioGarreta Rufas Speaker antonio.garreta_rufas@boehringer-ingelheim.comGermany Innovative Strategies for Clinical Trial Design in IgAN JeffreyHafkin Speaker jeffrey.hafkin@otsuka-us.comUnited States LokeshShah Speaker lokesh.shah@otsuka-us.comUnited States Improving Outcomes in Complement-mediated Kidney Diseases Marianne Silkjær Nielsen Speaker Msn@compcure.orgSwitzerland Advancing Mechanistic Trials through Industry–Academia Collaboration: Insights from the REMODEL Trial ManuelMayrdorfer Speaker mumf@novonordisk.comDenmark Why? When? How? How to Maximize Patient Outcomes From the Start of Dialysis PeterRutherford Speaker peter.rutherford@vantive.comSwitzerland 301 - 302																								Building Trust and Equity in Indigenous Transplant Care SamanthaBateman Moderator samantha.bateman@sa.gov.auAustralia Return to Country: Evaluating Health Service Bias and the Impact of Place-based Cultural Safety Initiatives KelliOwen Speaker kelli@anzdata.org.auAustralia ScottJones Speaker Scott.Jones@health.nsw.gov.auAustralia Equity in Action: Improving Access to Kidney Transplantation Through Community Partnerships in Rural, Remote, and Indigenous Communities AnuragSingh Speaker anuragsing@hotmail.comCanada Celebrating Cultural Inclusion and Safety in Academia and Medical Education LukeWilson Speaker luke.wilson@otago.ac.nzNew Zealand Q&A 303																								ISN-ISGD Joint Session Autoantibodies Targeting Podocyte-specific Antigens in Primary Nephrotic Syndrome TobiasHuber Speaker t.huber@uke.deGermany Insights from the Nephrotic Syndrome Study Network (NEPTUNE) and Cure Glomerulonephropathy (CureGN) groups AlessiaFornoni Speaker afornoni@med.miami.eduUnited States Podocyte-directed Progression of Kidney Injury in FSGS and DKD John CijiangHe Speaker cijiang.he@mssm.eduUnited States 304																								Navigating Ethical Challenges in End-of-Life Kidney Care DominiqueMartin Moderator dominique.martin@deakin.edu.auAustralia HeatherAscani Speaker ascanihk@med.umich.eduUnited States LauraBarisoni Speaker laura.barisoni@duke.eduUnited States NikkiBonevich Speaker bonevicn@med.umich.eduUnited States Building Trust and Hope in Kidney Failure Care NoriakiKurita Speaker kuritanoriaki@gmail.comJapan How Advance Care Planning Supports Kidney Care Decisions KathrynDucharlet Speaker kducharlet@hotmail.comAustralia Patient Involvement in Shaping End-of-Life Kidney Care Policies ManvirVictor Speaker jmanvir@gmail.comMalaysia Q&A 315																								Innovating Kidney Trials: PROMs, New Designs, and Global Roadmaps AdeeraLevin Moderator alevin@providencehealth.bc.caCanada MasaomiNangaku Moderator mnangaku@m.u-tokyo.ac.jpJapan Opening Remarks and Session Overview AdeeraLevin Speaker alevin@providencehealth.bc.caCanada Overcoming the Bottleneck: Endpoint Selection in Phase 2 Kidney Trials Kai-UweEckardt Speaker kai-uwe.eckardt@charite.deGermany Integrating Patient-Reported Outcomes (PROMs) Using Patient-reported Outcomes to Improve Kidney Research and Care AllisonJaure Speaker allison.jaure@sydney.edu.auAustralia Rethinking Kidney Trials: Innovative Designs for Modern Research Questions MegJardine Speaker meg.jardine@sydney.edu.auAustralia Designing Better Kidney Trials Using Hierarchical Composite Endpoints HiddoLambers Heerspink Speaker H.J.Lambers.Heerspink@umcg.nlNetherlands Panel Discussion & Q&A Closing Remarks MasaomiNangaku Speaker mnangaku@m.u-tokyo.ac.jpJapan 501 - 502																								Paediatric Transplantation: Identifying Patients at Risk What Will Be the Future of Personalised Immunosuppression in Children? LarsPape Speaker Lars.Pape@uk-essen.deGermany Can We Prevent FSGS Recurrence in Children? PriyaVerghese Speaker pverghese@luriechildrens.orgUnited States What Is the Role of Anti-Nephrin Antibody in Pediatric Kidney Transplantation? YukoHamasaki Speaker yuhamasaki@med.toho-u.ac.jpJapan Q&A 503																								Hot Debate: Friend or Foe: SUMOylation in Kidney Injury and Repair SUMOylation of Podocin Reverses the Progression of Diabetic Kidney Disease PedroGeraldes Speaker Pedro.Geraldes@USherbrooke.caCanada SUMOylation Activates β-Catenin and Contributes to Kidney Fibrosis ZhengDong Speaker zdong@augusta.eduUnited States Main Hall
5 p.m. 6 p.m.	Industry Symposium 26 YusukeSuzuki Moderator yusuke@juntendo.ac.jpJapan Evolving Landscape of IgA Nephropathy in 2026 and Beyond HongZhang Speaker hongzh@bjmu.edu.cnChina 303																								Industry Symposium 27 HITOSHISUZUKI Moderator shitoshi@juntendo.ac.jpJapan Welcome & Introduction HITOSHISUZUKI Speaker shitoshi@juntendo.ac.jpJapan Understanding IgA Nephropathy Worldwide: Presentation, Progression, and Epidemiology ShikhaWadhwani Speaker shikha.wadhwani@northwestern.eduUnited States Mechanistic insights: Exploring the Role of Complement in IgA Nephropathy Jonathan Barratt Speaker jb81@leicester.ac.ukUnited Kingdom Panel Discussion and Q&A Session & Closing Remarks HITOSHISUZUKI Speaker shitoshi@juntendo.ac.jpJapan 304																								Industry Symposium 25 ParthaDas Moderator parthadas@doctors.net.ukUnited Kingdom SharleneGreenwood Moderator sharlene.greenwood@nhs.netUnited Kingdom Improving ESKD outcomes in Brazil BrunoZawadzki Speaker drbzawadzki@gmail.comBrazil Identifying and managing CKD in Africa KateBramham Speaker kate.bramham@kcl.ac.ukUnited Kingdom Q&A 315																								Big Data Lab 3 - CELLxGENE 321																								Industry Symposium 30 YOSHITAKAISAKA Moderator isaka@kid.med.osaka-u.ac.jpJapan Transformative Insights from the DAPA-CKD Trial: Lessons for the Future of Kidney Care NaokiKashihara Speaker kashinao@med.kawasaki-m.ac.jpJapan 501 - 502																								Moderated Poster Session Exhibition Hall																								From Seed to Impact: Building Global Kidney Care Capacity through ISN Grants RobertWalker Moderator rob.walker@otago.ac.nzNew Zealand TakashiKobayashi Speaker t-koba@juntendo.ac.jpJapan FarnazNobi Speaker nobifarnaz@gmail.comBangladesh AhadQayyum Speaker drahadqayyum@gmail.comPakistan Spotlight Stage 1
5:15 p.m. 6:15 p.m.	The Kidney Tank 3.0 - The Japanese Version SwapnilHiremath Speaker shiremath@toh.caCanada MythriShankar Speaker mythri.nish@gmail.comIndia ManjushaYadla Speaker manjuyadla@gmail.comIndia Spotlight Stage 2
5:30 p.m. 6:15 p.m.	Your Nephrology Journey: Generalist or Specialist? AhadQayyum Speaker drahadqayyum@gmail.comPakistan Kanako Terakawa Speaker k.terakawa.med@gmail.comJapan NikolayBulanov Speaker nmbulanov@gmail.comRussia SabineKaram Speaker sabinejkaram@gmail.comUnited States YannickNlandu Speaker yannicknlandu@yahoo.frDemocratic Republic of Congo Spotlight Stage 1

30 March 2026

Time	Session

8:10 a.m. 9:10 a.m.	Industry Symposium 35 KatherineTuttle Moderator Katherine.Tuttle@providence.orgUnited States Mechanistic Effects of Semaglutide on Kidney Disease in Type 2 Diabetes: The REMODEL trial KatherineTuttle Speaker Katherine.Tuttle@providence.orgUnited States Multiparametric Imaging and Tissue Transcriptomics to Unravel Mechanisms of Kidney Protection MatthiasKretzler Speaker kretzler@umich.eduUnited States GLP1s in Combination With Other Therapies and Applications in Clinical Practice BrendonNeuen Speaker bneuen@georgeinstitute.org.auAustralia The Future of GLP1s and Other Incretin-based Therapies for Kidney Disease MasaomiNangaku Speaker mnangaku@m.u-tokyo.ac.jpJapan 301 - 302																																																																Industry Symposium 33 JunOh Moderator j.oh@uke.deGermany Welcome and introduction JunOh Speaker j.oh@uke.deGermany The burden of pediatric chronic kidney disease: Epidemiology, etiology and unmet needs KenjiIshikura Speaker lxkenzo@gmail.comJapan Studying pediatric chronic kidney disease: Challenges in evidence generation and clinical research HughMcCarthy Speaker hugh.mccarthy@health.nsw.gov.auAustralia The long-term consequences of childhood CKD: Growth, cardiovascular risk and adult outcomes JunOh Speaker j.oh@uke.deGermany Summary JunOh Speaker j.oh@uke.deGermany Discussion and Q&A 304																																																																Breakfast With the Editors: Publishing in Nephrology BradRovin Moderator rovin.1@osu.eduUnited States PierreRonco Moderator pierreronco@yahoo.frFrance Defining Vision and Scope PierreRonco Speaker pierreronco@yahoo.frFrance Introducing Kidney International Clinical Reports Journal SwapnilHiremath Speaker shiremath@toh.caCanada Choosing the Right Nephrology Journal PierreRonco Speaker pierreronco@yahoo.frFrance How Editors Assess Manuscripts BradRovin Speaker rovin.1@osu.eduUnited States Responding to Reviewer Comments JaiRadhakrishnan Speaker jr55@cumc.columbia.eduUnited States Dealing With Statistics in Kidney Research GermaineWong Speaker germaine.wong@health.nsw.gov.auAustralia From First Draft to First Author: Perspectives From a KI Editorial Fellow GriffithPerkins Speaker griffith.perkins@adelaide.edu.auAustralia Panel Discussion 313 - 314																																																																Industry Symposium 31 ChristineSkerka Moderator christine.skerka@googlemail.comGermany Complement Deregulation in C3 Glomerulopathy : A Diagnostic Perspective PeterZipfel Speaker peter.zipfel@live.comGermany Targeted Therapy for C3 Glomerulopathy: Exciting Changes for Patients and Nephrologists MichaelWiesener Speaker michael.wiesener@uk-erlangen.deGermany C3 Glomerulopathy: Current Concepts and Emerging Therapeutic Strategies DineshKhullar Speaker drdineshkhullar@gmail.comIndia 315																																																																Industry Symposium 36 HITOSHISUZUKI Moderator shitoshi@juntendo.ac.jpJapan Overview of Unmet Need in IgA Nephropathy and Disease Markers AdrianLiew Speaker draliew2@gmail.comSingapore Emerging Therapeutics Targets in IgAN: The Role of BAFF and APRIL SuceenaAlexander Speaker suceena@gmail.comIndia Targeting BAFF and APRIL with Atacicept RichardLafayette Speaker czar@stanford.eduUnited States 501 - 502																																																																Industry Symposium 34 SHOICHIMARUYAMA Moderator marus@med.nagoya-u.ac.jpJapan Chair's welcome SHOICHIMARUYAMA Moderator marus@med.nagoya-u.ac.jpJapan Evolution of C3G and primary IC-MPGN disease understanding: from molecular mechanisms to addressing patient needs EdwinWong Speaker edwin.wong1@nhs.netUnited Kingdom A race against time: the value of an early and accurate diagnosis Seung HyeokHan Speaker hansh@yuhs.acSouth Korea Panel discussion: Looking to the future: time to support our patients SHOICHIMARUYAMA Moderator. marus@med.nagoya-u.ac.jpJapan Q&A and close SHOICHIMARUYAMA Moderator. marus@med.nagoya-u.ac.jpJapan 503
9:25 a.m. 10:55 a.m.	ISN-JSN Joint Session: Bioengineering the Kidney of the Future Shaping the Future of Kidney Regeneration TakashiYokoo Speaker tyokoo@jikei.ac.jpJapan From iPS Cells to Kidneys: A Roadmap to Regeneration KenjiOsafune Speaker osafu@cira.kyoto-u.ac.jpJapan Breakthrough Discoveries Shaping the Future of Kidney Repair YunXia Speaker yunxia@ntu.edu.sgSingapore Cutting-Edge Strategies in Kidney Regeneration JonathanHimmelfarb Speaker jonathan.himmelfarb@mssm.eduUnited States Q&A 301 - 302																																																																New Precision Therapies in Kidney Care Adeno-associated Viral Therapy in Kidney Diseases HiroyukiNakai Speaker nakaih@ohsu.eduUnited States CAR-T Cell Therapy in Lupus BradRovin Speaker rovin.1@osu.eduUnited States Cellular Immunotherapy in Kidney Transplantation TambiJarmi Speaker Jarmi.Tambi@mayo.eduUnited States TBC Q&A 303																																																																ISN-YNC Joint Session: Youthful Insights on Aging Kidneys AhadQayyum Panel drahadqayyum@gmail.comPakistan BiancaDavidson Panel bianca.davidson@gmail.comSouth Africa HannahBeckwith Panel hannah.beckwith@kcl.ac.ukUnited Kingdom Winston Wing ShingFung Panel winstonwsfung@hotmail.comHong Kong, China Abstract winner TBD: highlighting young talent, providing opportunity to present Abstract winner TBD: highlighting young talent, providing opportunity to present Molecular Mechanisms of Kidney Aging: From Bench to Bedside TakeshiYamamoto Speaker tyamamoto@kid.med.osaka-u.ac.jpJapan Rethinking Goals of Care in Elderly Dialysis Patients HannahBeckwith Speaker hannah.beckwith@kcl.ac.ukUnited Kingdom Providing Care for the Aging Kidney in Low-resource Settings AhadQayyum Speaker drahadqayyum@gmail.comPakistan Synergy in Senescence: New Perspectives on Kidney Aging TakeshiYamamoto Speaker tyamamoto@kid.med.osaka-u.ac.jpJapan 304																																																																The ISN Journals Editorial Session: The Best of 2025 KI and KI Reports Articles BradRovin Moderator rovin.1@osu.eduUnited States GermaineWong Moderator germaine.wong@health.nsw.gov.auAustralia PierreRonco Moderator pierreronco@yahoo.frFrance Kidney International in Focus: Annual Highlights PierreRonco Speaker pierreronco@yahoo.frFrance ISN-KI Fellows: Showcasing Excellence, Part 1 — Pediatrics GabrielCara-Fuentes Speaker Gabriel.CaraFuentes@NationwideChildrens.orgUnited States ISN-KI Fellows: Showcasing Excellence, Part 2 — Clinical Nephrology SaharKoubar Speaker skoubar@umn.eduUnited States ISN-KI Fellows: Showcasing Excellence Part 3 — Epidemiology & Clinical Trials DavidTunnicliffe Speaker david.tunnicliffe@sydney.edu.auAustralia ISN-KI Fellows: Showcasing Excellence, Part 4 — Basic and Translational Science NahidTabibzadeh Speaker nahid.tabibzadeh@inserm.frFrance Kidney International Reports in Focus: Annual Highlights JaiRadhakrishnan Speaker jr55@cumc.columbia.eduUnited States Kidney International Reports in Focus: Annual Highlights JaiRadhakrishnan Speaker jr55@cumc.columbia.eduUnited States Kidney International Reports in Focus: Annual Highlights JaiRadhakrishnan Speaker jr55@cumc.columbia.eduUnited States Celebrating Excellence: Best Reviewer Awards Presentation BradRovin Speaker rovin.1@osu.eduUnited States Presentation of Basic Science Awards (Early Career Researcher Awards) BERNHARDDUMOULIN Speaker bernhard.dumoulin@gmail.comUnited States Presentation of Clinical Science Awards (Early Career Researcher Awards) Louis-CharlesDesbiens Speaker louischarles.desbiens@gmail.comCanada ISN-KI Fellows: Where Are They Now? GermaineWong Speaker germaine.wong@health.nsw.gov.auAustralia 315																																																																Integrating Care for Cardiovascular-Kidney-Metabolic Health Across the Lifespan Is Kidney Dysfunction in Heart Failure More Than Just Low Cardiac Output? BrendonNeuen Speaker bneuen@georgeinstitute.org.auAustralia Is Metabolic Dysfunction in Cardiovascular-Kidney-Metabolic Syndrome More Than Just Hyperglycemia and Obesity? HiddoLambers Heerspink Speaker H.J.Lambers.Heerspink@umcg.nlNetherlands Kidney at the Center of Cardiovascular-Kidney-Metabolic Syndrome MasaomiNangaku Speaker mnangaku@m.u-tokyo.ac.jpJapan What’s Next in Cardiovascular-Kidney-Metabolic Therapy? RobertoPecoits-Filho Speaker roberto.pecoits@arborresearch.orgUnited States Q&A 501 - 502																																																																Understanding and Treating Complement-Mediated Glomerular Disease VivekanandJha Moderator vjha@georgeinstitute.org.inIndia Applying Precision Medicine to Glomerular Disorders JonathanHimmelfarb Speaker jonathan.himmelfarb@mssm.eduUnited States Genetic Complementopathies and Kidney Disease AnujaJava Speaker ajava@wustl.eduUnited States Complement and IgA Nephropathy AdrianLiew Speaker draliew2@gmail.comSingapore Complement and Anti-Neutrophil Cytoplasmic Antibody-associated Vasculitis RosnawatiYahya Speaker rosnayahya@gmail.comMalaysia Q&A 503																																																																HIT! High Impact Clinical Trials 4 KeiFukami Moderator fukami@med.kurume-u.ac.jpJapan LizLightstone Moderator l.lightstone@imperial.ac.ukUnited Kingdom Effect of a 12-week Intradialytic Cycling Intervention on Hemodialysis-induced Myocardial Stunning: A Multi-centre Randomized Controlled Trial ClaraBohm Speaker cbohm@sogh.mb.caCanada Effect of Finerenone on Circulating Biomarkers: A CONFIDENCE Analysis MarioBerger Speaker mario.berger@bayer.comGermany Effect of Simultaneous Initiation of Finerenone and Empagliflozin on Urinary Albumin-to-creatinine Ratio by Age and Sex in the CONFIDENCE Trial RajivAgarwal Speaker ragarwal@iu.eduUnited States Estimated Glomerular Filtration Rate, Systolic Blood Pressure, and Urinary Albumin-to-creatinine Ratio — Unravelling the Interplay in Combination: Findings From the CONFIDENCE Trial RajivAgarwal Speaker ragarwal@iu.eduUnited States Lowering-Hyperuricemia Treatment on Cardiovascular Outcomes in Peritoneal Dialysis Patients: A Prospective, Multicenter, Double Blind Randomized Controlled Trial Naya Huang Speaker huangnaya@163.comChina Main Hall
11 a.m. 11:45 a.m.	Big Data Lab 4 - NephQTL portal 321																																																																Translating Knowledge Into Action: Implementing the ISN i3C CKDu Toolkit for Global Impact Understanding the CKDu Challenge: A Global Health Priority ErangaWijewickrama Speaker erangasw@gmail.comSri Lanka Inside the ISN i3C CKDu Toolkit: Structure, Stages, and Key Components Ana CatalinaAlvarez Elias Speaker anacatalina.alvarezelias@rriny.comUnited States From Knowledge to Action: Implementing the Toolkit for Global Impact Magdalena Madero Speaker madero.magdalena@gmail.comMexico Spotlight Stage 1																																																																Industry Spotlight Session 39 JosephineChow Moderator Josephine.Chow@health.nsw.gov.auAustralia Empowering Nurses is a Key for Home Dialysis Expansion JosephineChow Speaker Josephine.Chow@health.nsw.gov.auAustralia Q & A Session JosephineChow Moderator. Josephine.Chow@health.nsw.gov.auAustralia Spotlight Stage 2
11:35 a.m. 12:35 p.m.	Plenary Lecture 3: The Potential of Polypills in CKD (Anthony Rodgers, Australia) Schrier Award Presentation LilyMushahar Moderator lilymushahar@gmail.comMalaysia MotokoYanagita Moderator motoy@kuhp.kyoto-u.ac.jpJapan RobertKalyesubula Moderator rkalyesubula@gmail.comUganda AnthonyRodgers Speaker arodgers@georgeinstitute.orgAustralia Schrier Award Presentation The Potential of Polypills in CKD AnthonyRodgers Speaker arodgers@georgeinstitute.orgAustralia Main Hall
12:45 p.m. 1:15 p.m.	Social Media Impacts Nephrology Clinical Practice CristinaPopa Speaker cristina.adriana.popa90@gmail.comRomania DIVYABAJPAI Speaker divyaa24@gmail.comIndia Spotlight Stage 1
12:50 p.m. 1:50 p.m.	Industry Symposium 47 BradRovin Moderator rovin.1@osu.eduUnited States Intro + IgAN Case: Global Perspective BradRovin Speaker rovin.1@osu.eduUnited States IgAN Case: China Perspective HongZhang Speaker hongzh@bjmu.edu.cnChina IgAN Case: Japan Perspective HITOSHISUZUKI Speaker shitoshi@juntendo.ac.jpJapan 301 - 302																																																																Industry Symposium 44 YusukeSuzuki Moderator yusuke@juntendo.ac.jpJapan Welcome and introduction YusukeSuzuki Speaker yusuke@juntendo.ac.jpJapan Audience pooling Chee KayCheung Speaker ckc15@leicester.ac.ukUnited Kingdom Recent guidelines updates in IgAN-The rationale Chee KayCheung Speaker ckc15@leicester.ac.ukUnited Kingdom The old and the new to approaching treatment SaynaNorouzi Speaker sayna.nrz@gmail.comUnited States Summary and close YusukeSuzuki Speaker yusuke@juntendo.ac.jpJapan 303																																																																Industry Symposium 45 MasaomiNangaku Moderator mnangaku@m.u-tokyo.ac.jpJapan Welcome & Introductions MasaomiNangaku Speaker mnangaku@m.u-tokyo.ac.jpJapan UACR: The hidden marker of heart and kidney risk PamelaKushner Speaker pamkushner@hotmail.comUnited States RobertoPecoits-Filho Speaker roberto.pecoits@arborresearch.orgUnited States Live Q&A MasaomiNangaku Moderator. mnangaku@m.u-tokyo.ac.jpJapan The Impact of RAAS Dysregulation in Cardiorenal Disease Sydney Tang Speaker scwtang@hku.hkHong Kong, China Live Q&A MasaomiNangaku Moderator. mnangaku@m.u-tokyo.ac.jpJapan Closing Remarks MasaomiNangaku Moderator mnangaku@m.u-tokyo.ac.jpJapan 304																																																																Industry Symposium 43 AshokSarin Moderator drashoksarin@gmail.comIndia Paradigm Shift in Anemia Management: From ESAs to HIF-PHIs Prem PrakashVarma Speaker varmapp123@rediffmail.comIndia Real World Evidence with Desidustat: India's Contribution to the Global HIF Story DineshKhullar Speaker drdineshkhullar@gmail.comIndia Panel discussion - Optimizing Outcomes with HIF-PHIs in CKD Anemia ManishMalik Moderator. navyaanshumanish@gmail.comIndia Narayan Prasad Panel narayan.nephro@gmail.comIndia SandipBhattacharya Panel sandipkb65@gmail.comIndia DibyaSingh Shah Panel dibyasingh@hotmail.comNepal D SBhadauria Panel speaker@doc.comIndia 315																																																																Industry Symposium 48 NaokiSato Moderator nms-ns@nms.ac.jpJapan RajivAgarwal Moderator ragarwal@iu.eduUnited States Welcome & Introduction NaokiSato Speaker nms-ns@nms.ac.jpJapan Early Action, Stronger Protection BrendonNeuen Speaker bneuen@georgeinstitute.org.auAustralia Lower UACR, Optimized Outcomes RajivAgarwal Speaker ragarwal@iu.eduUnited States Finerenone, a CKM Pillar Jozine TerMaaten Speaker j.m.ter.maaten@umcg.nlNetherlands Changing Trajectories in Practice KeizoKanasaki Speaker kkanasakidr@gmail.comJapan Q&A and Closing Remarks / Panel Discussion NaokiSato Speaker nms-ns@nms.ac.jpJapan RajivAgarwal Speaker ragarwal@iu.eduUnited States 501 - 502																																																																Industry Symposium 46 YOSHITAKAISAKA Moderator isaka@kid.med.osaka-u.ac.jpJapan Welcome and introduction YOSHITAKAISAKA Moderator isaka@kid.med.osaka-u.ac.jpJapan Pathophysiology of C3G and Importance of Early Diagnosis YOSHITAKAISAKA Moderator isaka@kid.med.osaka-u.ac.jpJapan Case studies: Different Patient Profiles CarlaNester Speaker carla-nester@uiowa.eduUnited States DavidKavanagh Speaker David.Kavanagh@newcastle.ac.ukUnited Kingdom Paul Brinkkötter Speaker paul.brinkkoetter@uk-koeln.deGermany Guidelines and Redefining Standard of Care YOSHITAKAISAKA Moderator. isaka@kid.med.osaka-u.ac.jpJapan Audience Q&A YOSHITAKAISAKA Moderator. isaka@kid.med.osaka-u.ac.jpJapan Summary and close YOSHITAKAISAKA Moderator isaka@kid.med.osaka-u.ac.jpJapan 503
1 p.m. 2 p.m.	ISN Program Awards RobertWalker Moderator rob.walker@otago.ac.nzNew Zealand Henry H LWu Awardee honlinhenry.wu@health.nsw.gov.auAustralia SukanyaGovindan Awardee sukanyagovindan@gmail.comIndia PriyaPais Awardee priyapais@gmail.comIndia PhuTran Nguyen Trong Awardee tntphu@ctump.edu.vnVietnam Spotlight Stage 2
1:15 p.m. 2 p.m.	What Patients Tells Nurses (and Not Doctors) RachaelWalker Moderator. Rachael.walker@auckland.ac.nzNew Zealand Spotlight Stage 1
2:10 p.m. 3:10 p.m.	Onco-nephrology: Navigating the Complexities of Kidney Disease in Patients With Cancer Cancer Screening in Kidney Transplant Recipients and Dialysis Patients Chi Yuen SimonCheung Speaker simoncycheung@gmail.comHong Kong, China Chronic Kidney Disease After Childhood Cancer Maria JoseSoler Speaker mjsoler01@gmail.comSpain Palliative Care in Cancer Patients With Kidney Disease: The Nephrologist's Role Q&A 301 - 302																																																								Pregnancy and Kidney Disease: A Rapid-fire Clinical Update ISN Train the Trainer Program MichelleHladunewich Moderator michelle.hladunewich@sunnybrook.caCanada ShilpanjaliJesudason Moderator shilpa.jesudason@sa.gov.auAustralia ISN Train-the-Trainer Program Overview ShilpanjaliJesudason Speaker shilpa.jesudason@sa.gov.auAustralia Rapid Fire Update 1 BalaWaziri Speaker balawaziri@gmail.comNigeria Rapid Fire Update 2 RashaShemies Speaker rashasamir@mans.edu.egEgypt Q&A MichelleHladunewich Moderator. michelle.hladunewich@sunnybrook.caCanada 303																																																								ISN-YNC Session: Hot Debate: Can Xenotransplants and Stem Cells Replace Human Organ Donation? KornchanokVareesangthip Moderator kornchanok.ploy@gmail.comThailand Introduction Proposition Speech 1 UgochiOnu Speaker ugochionu2008@gmail.comNigeria Opposition Speech 1 HirakuTsujimoto Speaker hira_to_ber3598@yahoo.co.jpJapan Rebuttal and Proposition Speech 2 I-RuChen Speaker angiogenesisbody@gmail.comTaiwan Rebuttal and Opposition Speech 2 Milagros MelissaFlores Fonseca Speaker flores1984md@yahoo.comMexico Audience Participation And Questions From Judges KenjiMatsui Judge kematsui@gmail.comUnited States NihalBashir Judge nmustafabashir@hotmail.comUnited Arab Emirates Voting and Summary Announcement of Winner and Prize Presentation 304																																																								A Turning Point for Kidney Health: Global Impact of the WHO Resolution IfeomaUlasi Moderator ifeomaulasi@yahoo.co.ukNigeria Sydney Tang Moderator scwtang@hku.hkHong Kong, China Implementing the WHO Resolution on Kidney Health MarcelloTonelli Speaker cello@ucalgary.caCanada From Resolution to Reality: Translating Evidence-Based CKD Therapies into Health Systems DavidWheeler Speaker d.wheeler@ucl.ac.ukUnited Kingdom Panel Discussion 313 - 314																																																								World Veterinary Association AkiraYabuki Moderator yabu@vet.kagoshima-u.ac.jpJapan Structure and Function of the Feline Kidney: Clinical Perspectives on Disease Development TakakoShimokawa Speaker t-shimokawa@ous.ac.jpJapan Animal Model–Based Training and Success in Interventional Nephrology BernardoMoguel González Speaker bernardomoguel@hotmail.comMexico Physiological Functions of a Cetacean-specific Aquaporin MiwaSuzuki Speaker suzuki.miwa@nihon-u.ac.jpJapan Q&A 315																																																								Hot Debate: Complement Inhibition vs Nefecon in IgA Nephropathy – Which First for Patients at Risk? Complement Inhibition Should Be Considered Before Nefecon in Patients With IgAN at Risk of Progression VladoPerkovic Speaker vlado.perkovic@unsw.edu.auAustralia Nefecon Should Be Considered Before Complement Inhibition in Patients With IgAN at Risk of Progression HongZhang Speaker hongzh@bjmu.edu.cnChina 501 - 502																																																								ISN-ISPD Joint Session: Peritoneal Dialysis for Everyone, by Everyone, Everywhere LilyMushahar Moderator lilymushahar@gmail.comMalaysia Supporting Patients in Choosing Peritoneal Dialysis as a Treatment Option RajnishMehrotra Speaker rmehrotr@uw.eduUnited States Person-centered Multidimensional Support for Patients on Home Dialysis RachaelWalker Speaker Rachael.walker@auckland.ac.nzNew Zealand Peritoneal Dialysis for Older Adults With Kidney Failure EdwinaBrown Speaker e.a.brown@imperial.ac.ukUnited Kingdom Hybrid Dialysis Models for Long-term Kidney Replacement Therapy YasuhikoIto Speaker yasuito57@gmail.comJapan Q&A 503																																																								ISN-Lancet Joint Session: New Series on Chronic Kidney Disease AdeeraLevin Moderator alevin@providencehealth.bc.caCanada JenniferLees Moderator jennifer.lees@glasgow.ac.ukUnited Kingdom MidoriSakashita Moderator msakashita-tky@umin.ac.jpJapan Advances in the Diagnosis and Detection of CKD LuxiaZhang Speaker zhanglx@bjmu.edu.cnChina Advances in Understanding the Impact of Sex on Kidney Health and Disease KateStevens Speaker kate.stevens@glasgow.ac.ukUnited Kingdom Advances in CKD Therapeutics in the Context of Complex Disease Interactions AndrejSkoberne Speaker andrej.b.skoberne@gmail.comSlovenia Q&A Main Hall																																																								Industry Spotlight Session 50 Atul DattatreyaSajgure Moderator atulsajgure@yahoo.comIndia JavedVakil Moderator jmvakvakil@gmail.comIndia T Balasubramaniyan Speaker mmcnephro@gmail.comIndia SiddharthLakhani Speaker siddharthlakhani1@gmail.comIndia Neuropathic Pain in CKD and Dialysis T Balasubramaniyan Speaker mmcnephro@gmail.comIndia Current and Emerging Therapies for Peripheral Neuropathy in CKD & Dialysis PratikDas Speaker drpratiktumpa.das70@gmail.comIndia Spotlight Stage 1
3:15 p.m. 3:45 p.m.	Squid Game Season 2: A Thrilling Game to Learn Kidney Genetics DanielO'Hara Moderator. daniel.ohara@sydney.edu.auAustralia Becky MingyaoMa Moderator. mymbecky@gmail.comHong Kong, China Spotlight Stage 1																																																																Industry Spotlight Session 51 RajivAgarwal Moderator ragarwal@iu.eduUnited States The Pillar Perspective: A Deep Dive Into Clinical Evidence RajivAgarwal Speaker ragarwal@iu.eduUnited States Panel Discussion Multimodal Management of CKD and HF RajivAgarwal Moderator. ragarwal@iu.eduUnited States Jozine TerMaaten Panel j.m.ter.maaten@umcg.nlNetherlands NaokiSato Panel nms-ns@nms.ac.jpJapan Spotlight Stage 2
3:50 p.m. 4:50 p.m.	From Ground Zero: Building Kidney Transplant Programs in Resource-limited Settings LilyMushahar Moderator lilymushahar@gmail.comMalaysia Paediatric Transplantation in LMICs: Building Family-Centered Infrastructure PriyaPais Speaker priyapais@gmail.comIndia Against the Odds: Establishing a Hospital-Based Transplant Program in Cameroon GloriaAshuntantang Speaker gloria.ash60@gmail.comCameroon Collaboration and Commitment: Malaysia's Journey Toward Transplant Independence Muhammad IqbalAbdul Hafidz Speaker fmeu6038@gmail.comMalaysia Q&A 301 - 302																																																															The Global Kidney Health Atlas: Advancing Equity and Excellence in Kidney Care Worldwide Opening & Session Introduction AdeeraLevin Moderator alevin@providencehealth.bc.caCanada Tracking Kidney Care Capacity: The ISN-Global Kidney Health Atlas 2025 Update SomkanyaTungsanga Speaker s.tungsanga@gmail.comCanada Regional Perspectives: Gaps and Successes in Kidney Care Delivery ArpanaIyengar Speaker arpanaiyengar@gmail.comIndia Innovation & Collaboration for Better Kidney Health AminuBello Speaker aminu1@ualberta.caCanada Future Directions: Questions and Closing Remarks HiroshiNishi Speaker hrnishi-tky@umin.ac.jpJapan 303																																																															ISN-IPNA session Emerging Treatments for Pediatric Nephrotic Syndrome KoichiNAKANISHI Speaker knakanis@cs.u-ryukyu.ac.jpJapan Therapies for Nephrotic Syndrome: Short‑Term Impact, Long‑Term Promise Identify opportunities to integrate short‑term treatment gains with long‑term management strategies RulanParekh Speaker rulan.parekh@wchospital.caCanada What Clinicians Should Know About Anti-CD20 Monoclonal Antibodies in Childhood Nephrotic Syndrome Eugene Yu HinChan Speaker genegene.chan@gmail.comHong Kong, China Q&A 304																																																															Autoantibody-mediated Kidney Disease Anti-nephrin Mediated Podocytopathy Felicitas E.Hengel Speaker f.hengel@uke.deGermany PLA2R Epitope Pairing is Essential for Complement Activation in Membranous Nephropathy Cheng-LungKu Speaker clku@cgu.edu.twTaiwan What’s New in Anti-GBM Antibody Research Ming-huiZhao Speaker mhzhao@bjmu.edu.cnChina Q&A 313 - 314																																																															ISN–DICG Joint Session: Confronting Organ Trafficking — Policy, Ethics, and Prevention GloriaAshuntantang Moderator gloria.ash60@gmail.comCameroon Mandatory Reporting of Suspicious Transplant-related Cases Maria AmaliaMatamoros Speaker amalia.matamoros@gmail.comCosta Rica Incentives to Reduce Organ Shortage KhalidaBulhan - Soki Speaker drkbsoki@gmail.comKenya Addressing Inequities to Prevent Organ Trafficking and Transplant Tourism LiliaCervantes Speaker Lilia.Cervantes@cuanschutz.eduUnited States Q&A 315																																																															Glomerular Disease Beyond the Kidney: Extraglomerular Manifestations Patient-reported Outcomes in Glomerular Disease: Considering the Whole Person MichelleO'Shaughnessy Speaker michelleoshaugh@gmail.comIreland Infectious Complications in Primary Glomerular Disease: Ensuring the Cure Isn’t Worse Than the Disease BalazsOdler Speaker balazs.odler@medunigraz.atAustria Cardiovascular Disease in Primary Glomerular Diseases: Quantifying and Reducing Risk MarkCanney Speaker mcanney@toh.caCanada Q&A 501 - 502																																																															ISN-ADQI Joint Session: Implementation Science and AKI in Acute Kidney Care MarliesOstermann Moderator m.ostermann@nhs.netUnited Kingdom Why Implementation Science Matters in Acute Kidney Care YuvaramReddy Speaker yuvaram.reddy@pennmedicine.upenn.eduUnited States What Is the Acute Disease Quality Initiative (ADQI) and Why Do We Need ADQI XXXV? MarliesOstermann Speaker m.ostermann@nhs.netUnited Kingdom What Did We Learn From ADQI XXXV? OleksaRewa Speaker rewa@ualberta.caCanada Q&A 503																																																															Anemia Care in CKD: Recent Evidence and Future Directions Chuan-MingHao Moderator chuanminghao@fudan.edu.cnChina Implementing Updated KDIGO Recommendations for CKD Anemia WolfgangWinkelmayer Speaker winkelma@bcm.eduUnited States Why CKD Anemia Care Differs Across Regions SunitaBavanandan Speaker sbavanandan@gmail.comMalaysia Beyond Erythropoiesis-stimulating Agents and Iron: Navigating the Future of Anemia of Chronic Kidney Disease Management Kai-UweEckardt Speaker kai-uwe.eckardt@charite.deGermany Q&A Main Hall
5 p.m. 6 p.m.	Industry Symposium 59 TakashiYokoo Moderator tyokoo@jikei.ac.jpJapan Welcome and introduction From evidence to practice: SGLT2 inhibitors as a foundational treatment for patients With CKD BeatrizFernandez-Fernandez Speaker bfernandez@fjd.esSpain Prompt action in CKD: increasing treatment benefits for your patients with CKD Iande Boer Speaker deboer@uw.eduUnited States The hidden burden: managing cardiovascular risk in patients with CKD BrendonNeuen Speaker bneuen@georgeinstitute.org.auAustralia Audience Q&A Summary and close 301 - 302																																																															Industry Symposium 56 MotokoYanagita Moderator motoy@kuhp.kyoto-u.ac.jpJapan The Significance of Potassium Management in CKD Treatment HidekiYokoi Speaker yokoih@kuhp.kyoto-u.ac.jpJapan 303																																																															Industry Symposium 57 MasaomiNangaku Moderator mnangaku@m.u-tokyo.ac.jpJapan The Future of Lupus Nephritis: Achieving Renal Protection Through Proteinuria Control SHOICHIMARUYAMA Speaker marus@med.nagoya-u.ac.jpJapan A New Era in Lupus Nephritis: Clinical Evidence and Therapeutic Positioning of Triple Therapy KeijuHiromura Speaker hiomura@gunma-u.ac.jpJapan 304																																																															Industry Symposium 55 Opening Remarks Optimal Timing of Treatment Initiation and Monitoring Strategies for Fabry Disease Patients in Korea Eun HuiBae Speaker baedak@hanmail.netSouth Korea New Therapeutic Strategies for Fabry Disease HidekiFujii Speaker fhideki@med.kobe-u.ac.jpJapan Discussion Closing Remarks 315																																																															Industry Symposium 58 HITOSHISUZUKI Moderator shitoshi@juntendo.ac.jpJapan Tonsillectomy for IgA nephropathy MikiTakahara Speaker miki@asahikawa-med.ac.jpJapan Impact of Intestinal Barrier Dysfunction on IgA Deposition in the Glomeruli KojiHase Speaker hase.a6@keio.jpJapan 503																																																															Moderated Poster Session Exhibition Hall																																																															Clinical Trials Demystified: How ISN TrialWatch and the Guide for Everyone Empower Understanding and Participation Building Clinical Trial Awareness in the Kidney Community Andrea Viecelli Speaker andrea.viecelli@usz.chSwitzerland ISN TrialWatch: Bringing the Latest Evidence to the Kidney Community MeganBorkum Speaker mborkum@gmail.comCanada The ISN Guide for Everyone: Demystifying Clinical Research AdeeraLevin Speaker alevin@providencehealth.bc.caCanada Spotlight Stage 1																																																															Support Your Non-Physician Kidney Care Allies: Launch of a Global Curriculum by ISN Emerging Leaders cohort 3 MythriShankar Moderator mythri.nish@gmail.comIndia Becky MingyaoMa Moderator mymbecky@gmail.comHong Kong, China MarekKollar Moderator marek.kollar@ikem.czCzech Republic Spotlight Stage 2
5:30 p.m. 6 p.m.	When Disasters Are the Norm: A 2050 Kidney Care Simulation MarinaWainstein Moderator marinawainstein@outlook.comArgentina SabineKaram Moderator sabinejkaram@gmail.comUnited States Micro-scenario 1: Water Disruption — a 2050 Simulation Vignette SayakaIshigaki Speaker ishigaki@hama-med.ac.jpJapan Micro-Scenario 2: Digital Outage and Logistics Delay Chia-TerChao Speaker b88401084@gmail.comTaiwan A Set of “Resilience Provocations” for 2050 Kyung DonYoo Speaker ykd9062@gmail.comSouth Korea Spotlight Stage 1																																																																Women in Nephrology: Home Dialysis Perspectives From Three Regions MalaSachdeva Moderator msachdeva@northwell.eduUnited States Women in Nephrology USA: Regional Experience and Insights MalaSachdeva Speaker msachdeva@northwell.eduUnited States Women in Nephrology in India: Progress, Barriers, and Opportunities UrmilaAnandh Speaker uanandh@gmail.comIndia Women in Nephrology in Africa: Lessons Learned KhalidaBulhan - Soki Speaker drkbsoki@gmail.comKenya Questions and Answers Spotlight Stage 2

31 March 2026

Time	Session

8 a.m. 9 a.m.	Industry Symposium 61 MotokoYanagita Moderator motoy@kuhp.kyoto-u.ac.jpJapan Revisiting MR-Mediated Electrolyte Imbalance at the Tissue Level: Implications for MR Blockade and JSH2025 Guidelines KentoKitada Speaker kitada.kento@kagawa-u.ac.jpJapan 303
9:10 a.m. 10:40 a.m.	Kidney Health in Pregnancy: Solutions to a Growing Challenge DIVYABAJPAI Moderator divyaa24@gmail.comIndia KateBramham Moderator kate.bramham@kcl.ac.ukUnited Kingdom Global Snapshot of Pregnancy-associated Acute Kidney Injury: Results From the 2025 Global Survey KatherineClark Speaker katherine.clark@kcl.ac.ukUnited Kingdom Improving Pregnancy-related Kidney Disease Diagnosis RashaShemies Speaker rashasamir@mans.edu.egEgypt Emerging Strategies for CKD Care During Pregnancy DIVYABAJPAI Speaker divyaa24@gmail.comIndia Implementing Simple, Scalable, Co-designed Solutions for Kidney Health in Policy and Practice StephenMutiso Speaker stephenmutiso@gmail.comKenya Q&A 301 - 302				ISN-TTS Joint Session: Maximising Opportunities and Resources in Kidney Transplant Care GeorginaIrish Moderator georgina@anzdata.org.auAustralia Using Causal Inference to Study Gender Gaps in Transplant Access JessicaHarding Speaker jessica.harding@emory.eduUnited States Pragmatic Medicine: Learning From the Indian Experience Shyam BihariBansal Speaker drshyambansal@gmail.comIndia Helping Patients Manage Medications and Complex Health Systems GermaineWong Speaker germaine.wong@health.nsw.gov.auAustralia Reducing the Environmental Footprint in Transplantation IvoLaranjinha Speaker ivolaranjinha@gmail.comPortugal Q&A 303				Genetic Testing in Kidney Disease: Interpretation and Patient Perspectives Genetic Pretesting — Is More Always Better? RoserTorra Speaker rtorra@fundacio-puigvert.esSpain The Test: Nephro-genomic Board Simulation: Variant Scientist X Genetic Nephrologist DanielGale Speaker d.gale@ucl.ac.ukUnited Kingdom Risk Alleles and Low-penetrance Variants in Nephrology: Gaps in Evidence JanewitWongboonsin Speaker jwongboonsin@gmail.comThailand The Patient Voice SusieGear Speaker susiegear@alportuk.orgUnited Kingdom Q&A Main Hall
11 a.m. 12 p.m.	ISN-JSDT Joint Session TadashiTomo Moderator tomo@oita-u.ac.jpJapan Dialysis Membranes and Patient Survival AbeMasanori Speaker abe.masanori@nihon-u.ac.jpJapan Sex-specific Outcomes and Prognosis in Dialysis Care SaoriNishio Speaker saorin@med.hokudai.ac.jpJapan Practical Aspects of Preserving the Peritoneal Dialysis Membrane Ana Elizabeth Figueiredo Speaker anaef@pucrs.brBrazil 301 - 302			Climate and Conflict: Protecting Kidney Health Amid Global Disruptors Diabetes Masculinises the Risk for Progressive Nephropathy of Indigenous Australian Females With CKD: The CKD.QLD Experience Green Nephrology: Rethinking Sustainability in Dialysis Systems Winston Wing ShingFung Speaker winstonwsfung@hotmail.comHong Kong, China Heat, Sweat, and Silence: Two Decades of Uncovering Mesoamerican Nephropathy RamonGarcia Trabanino Speaker rgtrab@gmail.comEl Salvador When Funding Fades: Geopolitical Shifts and Kidney Health in Fragile Settings GraceKansiime Speaker graekan@gmail.comUganda Q&A 303			Cutting Edge Science in Diabetic Kidney Disease Complement Activation in Diabetic Kidney Disease MinChen Speaker chenmin74@sina.comChina Applying Spatial Transcriptomics to Diabetic Kidney Disease Research BERNHARDDUMOULIN Speaker bernhard.dumoulin@gmail.comUnited States Applying Metabolomics to Understand Diabetic Kidney Disease ReikoInagi Speaker inagi-r@m.u-tokyo.ac.jpJapan Q&A 304			ISN-JSN-APSN Joint Session: Delivering Kidney Care in Humanitarian Crises KeiFukami Moderator fukami@med.kurume-u.ac.jpJapan LilyMushahar Moderator lilymushahar@gmail.comMalaysia SerhanTuglular Moderator serhantuglular@yahoo.comTurkey The ISN Role in Humanitarian Kidney Care AliAbu-Alfa Speaker abualfa@aub.edu.lbLebanon Disaster Preparedness in Kidney Care: Pitfalls and Solutions SerhanTuglular Speaker serhantuglular@yahoo.comTurkey Earthquake Disaster: Lessons Learnt from Japan KeiFukami Speaker fukami@med.kurume-u.ac.jpJapan Resilient Kidney Care: Adaptation and Recovery After a Disaster SabineKaram Speaker sabinejkaram@gmail.comUnited States Q&A Main Hall
12:10 p.m. 1:10 p.m.	Plenary Lecture 4: Hugh de Wardener Lecture - Creating Paradigm Shifts in Medical Diagnostics Using Liquid Biopsy (Dennis Lo, Hong Kong, China) MegJardine Moderator meg.jardine@sydney.edu.auAustralia ShuchiAnand Moderator sanand2@stanford.eduUnited States Yuk Ming DennisLO Speaker loym@cuhk.edu.hkHong Kong, China Creating Paradigm Shifts in Medical Diagnostics Using Liquid Biopsy Yuk Ming DennisLO Speaker loym@cuhk.edu.hkHong Kong, China Congress Closing Main Hall